Identification of 2,4

Scientific Reports volume 13, Article number: 14292 (2023) Cite this article

Metrics details

The compound 2,4-diacetylphloroglucinol (DAPG) is a broad-spectrum antibiotic that is primarily produced by Pseudomonas spp. DAPG plays an important role in the biocontrol disease suppressing activity of Pseudomonas spp. In the current study, we report the discovery of the DAPG biosynthetic cluster in strains of Chromobacterium vaccinii isolated from Brazilian aquatic environments and the distribution of the biosynthetic cluster in the Chromobacterium genus. Phylogenetic analysis of the phlD protein suggests the biosynthetic cluster probably entered the genus of Chromobacterium after a horizontal gene transfer event with a member of the Pseudomonas fluorescens group. We were able to detect trace amounts of DAPG in wild type cultures and confirm the function of the cluster with heterologous expression in Escherichia coli. In addition, we identified and verified the presence of other secondary metabolites in these strains. We also confirmed the ability of C. vaccinii strains to produce bioactive pigment violacein and bioactive cyclic depsipeptide FR900359. Both compounds have been reported to have antimicrobial and insecticidal activities. These compounds suggest strains of C. vaccinii should be further explored for their potential as biocontrol agents.

The compound 2,4-diacetylphloroglucinol (DAPG) is a broad-spectrum antibiotic that was originally isolated from a fluorescent Pseudomonas strain1. DAPG is synthesized by a type III polyketide synthase cluster comprising the phlABCDE operon2,3. The synthesis is initiated by the phlD gene, which produces phloroglucinol from malonyl-CoA2. Phloroglucinol is subsequentially acylated to produce monoacetylphloroglucinol (MAPG), and a second acylation leads to the production of DAPG4.

Subsequently, this molecule can be used to suppress disease causing organisms in soil and is an important component of “disease suppressive soils”5 and in biocontrol applications6. DAPG is highly effective in controlling the causal agent of “take-all decline” in wheat (Gaeumannomyces tritici)7 and “tobacco black root rot” (Thielaviopsis basicola)8. In addition to controlling these fungal ascomycetes, DAPG has been reported to inhibit the oomycete Pythium ultimum9, the Gram negative bacterium Erwinia carotovora subsp. atroseptica10 and the Gram-positive bacterium Clavibacter michiganensis subsp. michiganensis11. The ecology and use of DAPG in biocontrol applications remains under intensive study12,13,14.

Chromobacterium species belong to the Gram-negative class of bacteria, Betaproteobacteria. Strains of Chromobacterium have been studied for many reasons such as their ability to be an opportunistic pathogen15 and as a model system for quorum sensing in Gram-negative bacteria16. Chromobacterium have been a rich source of bioactive molecules17,18,19. Recently, they have been used and developed as biocontrol agents to control insect pests20,21 and to control plant pathogens22,23,24,25.

In this study, while exploring the diversity of Chromobacterium in a Brazilian river system, we identified strains of Chromobacterium vaccinii that possessed a polyketide synthase biosynthetic cluster with homology to the phlACBDE operon26. This provided motivation to determine the distribution of this cluster in Chromobacterium spp. and confirm the bioactivity of the cluster.

The type strain of C. vaccinii DSM 25150T was obtained directly from the DSMZ-German Collection of Microorganisms and Cell Cultures. Chromobacterium vaccinii CR1 and CR5 were previously isolated from aquatic environments in Brazil26. Both strains were isolated from raw surface water, which was collected directly in sterile flasks from the body of water between 0 and 30 cm water depth, in which the collection and preservation of the samples occurred in accordance to the National Collection Guide and preservation of samples: water, sediment, aquatic communities and liquid effluents27. C. vaccinii CR1 was isolated from João Leite stream, Goiânia, Goiás, Brazil—Geographic location 16° 34′ 30.54" S; 49° 13′ 55.02" W. C. vaccinii CR5 was isolated from the Meia Ponte river, Goiânia, Goiás, Brazil—geographic location 16° 54′ 16.3'' S; 49° 07′ 37.8'' W. The isolation details were according to Gomes et al.28.

The aquatic environment where strains CR1 and CR5 were isolated from is a river and its tributary. These waters are also impacted by many anthropological pressures, such as industrial, agro-industrial activities (livestock and an intense production of horticultural products), in addition to being used for leisure. The climate of the basin is tropical with two well-defined seasons, dry and rainy, belonging to the Cerrado biome28.

The website version of the antiSMASH 6.0 software was used to identify putative secondary metabolite clusters in the genomes of C. vaccinii CR1, CR5, and DSM 25150T29. Clusters that were not reliably assigned in the antiSMASH 6.0 software were manually searched using BLAST software to determine a potential function. To determine the distribution of the DAPG cluster, the cluster (identified as GenBank LQR3212800..LQR32_12830) was used as a reference. These loci were manually searched using BLAST software against all available genomes (as of June 1, 2022) in the Chromobacterium genus. In addition to the biosynthetic genes of the DAPG cluster (phlACBDE), we searched for the regulatory gene associated with the cluster (phlF, phlG, phlH) commonly found in Pseudomonas strains, accession: CM001558 was used as a reference.

The core genome for the Chromobacterium genus was determined and aligned using the BIGSdb program30. Aquitalea magnusonii DSM 23134T was included as an outgroup. The phylogenetic tree was constructed using MEGA 11 software31. The neighbor-joining tree was determined using the Tamura-Nei model (0.40, gamma distributed with invariant sites). Measures of bootstrap support for internal branches were obtained from 1000 pseudoreplicates. For the PhlD phylogeny, the PhlD protein was identified in the genome of C. vaccinii CR1 and searched using BLAST software against all available non-redundant proteins in GenBank. All proteins available (9) in the Chromobacterium genus were included in the alignment. Due to the large number of Pseudomonas proteins available, only a representative sample (11) were included. A Streptomyces sp. protein (PhiD) was used as an outgroup. All alignments were performed using MUSCLE implemented under MEGA 1131. The alignment was model tested in MEGA 11 and the Maximum Likelihood method with WAG model was selected. Measures of bootstrap support for internal branches were obtained from 1000 pseudoreplicates.

Genomic DNA was extracted from 1 ml of an overnight culture of C. vaccini DSM 25150T as previously described by32. The putative phlACB cluster (~ 2.8 KB) was amplified from C. vaccini DSM 25150T genomic DNA using the primers cluster F (ATG AAG AAG GCA GGC ATA GTG AGC TAT GGC AG) and cluster R (ATC TTC CAG CAC GAA CTT GTA GGC GTA TTG CCA) using Invitrogen Platinum SuperFi II DNA polymerase (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. The gel purified PCR product was reamplified with new primers containing the restriction sites Nco I (5ʹ end) and Hind III (3ʹ end) for cloning into the pET28b expression vector. Following ligation, three independent expression clones with the phlACB cluster were identified from plasmids that had been transformed into E. coli DH 5α. The correct sequence of the amplified phlACB cluster in each clone was verified by comparison to the genome sequence of C. vaccini CR1 following sequencing of each clone using a MiSeq DNA sequencer. The plasmid clones phlACB.1, phlACB.3 and phlACB.5, as well as empty vector pET28b, were individually transformed into BL21 E. coli.

Each E. coli BL21 phlACB cell line, as well as the control BL21 cells with pET28b, was grown overnight in LB broth with kanamycin (50 µg/ml). The overnight culture was then used to inoculate M9 minimal medium (200 µl of inoculum into 10 ml media) with kanamycin (50 µg/ml) and grown at 37 °C with shaking (180 RPM) until the OD 600 reached 0.6. Afterwards, each culture received 1 mg of DAPG (dissolved in ethanol, Cayman Chemical, Ann Arbor, Michigan) and Isopropyl-β-d-1-thiogalactopyranoside (IPTG) for a final concentration of 0.2 mM, and incubated at 30 °C Aliquots of the cultures were removed at various time points and stored at 4 °C.

For each time point (1, 2, 3, 4, and 7 days) and each media condition (LB or KMB), 5 μL of Chromobacterium culture media was analyzed by LC–MS using a Vanquish HPLC equipped with an ODS-18 column (3 mm × 150 mm, 3 μm particle size, Inertsil, GL Sciences, Inc., Torrance, CA) elution of analytes was accomplished by a linear gradient form 5:95–95:5% 18 MΩ water + 0.1% formic acid: Optima grade methanol + 0.1%formic acid at a flow rate of 0.550 ml/min over 30 min at 50 °C. Column effluent was monitored by UV at wavelengths 254 nm, 280 nm, and 270 nm prior to introduction into an Orbitrap ID-X- tribrid mass spectrometer (ThermoElectron, West Palm Beach, CA) under Xcalibur 4.4 control. Mass spectral data from 200 to 2000 Da m/z were collected in the orbitrap at 120,000 resolution. Tandem mass spectral data of target metabolites was collected using higher-energy collision dissociation (HCD, CE = 25 and 35) in the Orbitrap analyzer.

Aliquots of E. coli media at times 8, 20.5, 28.5, 48, and 68 h from three transformants (pET28-phlACB-1, -3, -5) and one plasmid-only control (pET28) were centrifuged at 10,000 RPM for 10 min. A sample of the supernatant (250 μL) was removed and diluted with 250 μL 18 MΩ water. A portion of this dilution (5 μL) was analyzed by LC–MS under the same LC conditions listed above, with the only modification to the mass spectrometric analyses was to lower the mass of detection to 100–1000 Da m/z to allow for the detection of phloroglucinol and MAPG. Authentic standards for DAPG, and phloroglucinol (Acros Organics, Geel, Belgium) were analyzed at 100 μg/ml to establish retention times and MS2 fragmentation patterns of expected products. Based on the manufacturer's specifications the level of detection of these analytes is approximately 100 pg/ml under these conditions.

Chromobacterium vaccinii strains CR1 and CR5 were originally isolated from aquatic environments in the state of Goiás, Brazil26. The type strain of C. vaccini DSM 25150T was also included in the analysis33. Table 1 shows five clusters were found across all three strains. The antiSMASH software was only able to assign the function of the violacein and the potential DAPG clusters. A large 68.4 kb trans-AT-PKS cluster was identified using BLAST software to be the biosynthetic cluster of cyclic depsipeptide FR90035934. The final two small clusters (6.9 and 8.6 kb) possess domains that suggests they are probable siderophores.

The initial discovery of the potential DAPG biosynthetic cluster in genomes of select C. vaccinii strains prompted the exploration of the distribution of this cluster in the Chromobacterium genus, given the historical importance of this molecule that is normally found in Pseudomonas spp. strains12. After a broader investigation using all available Chromobacterium genomes, the cluster was identified in 11 genomes in the genus that appeared in three main clades (Fig. 1). The results show the cluster was found in all C. vaccinii genomes and a closely related Chromobacterium piscinae strain. A second clade containing the cluster was identified in Chromobacterium sphagni. The third clade was consists of Chromobacterium amazonense and a closely related, recently described new species of Chromobacterium sinusclupearum35. The cluster had a broad geographical distribution with seven of the strains from the United States36,37,38, two from Brazil26, one from China (CP022344), and one from Malayasia39.

Distribution of DAPG and depsipeptide FR900359 biosynthetic clusters in Chromobacterium genus. The phylogeny is based on the core genome of the strains listed in the figure. Measures of bootstrap support for internal branches were obtained from 1000 pseudoreplicates. Aquitalea magnusonii DSM 23134T was used as an outgroup and not shown.

All the biosynthetic genes of the DAPG cluster (phlACBDE) were found in all of the Chromobacterium strains reported to contain the cluster. Interestingly, the Chromobacterium strains do not contain all the regulatory genes associated with this cluster in Pseudomonas strains. Typically, the DAPG cluster in Pseudomonas strains contain the phlF, phlG and phlH genes, which are known to regulate the expression of the cluster12. The Chromobacterium strains only contain the phlF gene and lack the phlG and phlH genes, which suggests they utilize a different regulatory mechanism than in Pseudomonas strains.

Additionally, the biosynthetic cluster for the depsipeptide FR900359 was also confined to the C. vaccinii genomes and one very closely related strain, C. piscinae XC0014. The violacein biosynthetic cluster was found in all genomes in Fig. 1, except for the two Chromobacterium phragmitis genomes.

A phylogeny of the polyketide synthase protein PhlD, which is fundamental to the DAPG cluster, was created to understand the possible origin on the cluster. Figure 2 shows the cluster was closely related to strains in the Pseudomonas fluorescens group40. The average amino acid identity between the proteomes of C. vaccinii CR1 and the closest Pseudomonas proteome was 47% while the average amino acid identity between two DAPG clusters was 80%. In all Chromobacterium genomes containing the cluster, the cluster was in the same physical region of the genome and shared the same flanking regions. A survey of Chromobacterium genomes lacking the cluster did not find any alternative genes or clusters at this insertion site.

Maximum likelihood phylogeny of PhlD protein from the DAPG biosynthetic cluster. Measures of bootstrap support for internal branches were obtained from 1000 pseudoreplicates.

To confirm the assignment and activity of the biosynthetic clusters LC–MS/MS was used to confirm the presence of the metabolites in culture. The three assigned biosynthetic clusters were violacein, depsipeptide FR900359, and DAPG. Figure 3 shows confirmation for the assignment of violacein and depsipeptide FR900359 using high accuracy mass spectrometry. For all three strains the violacein signal was strong and the depsipeptide FR900359 was much weaker. A very weak signal for DAPG was observed in the strains, which was consistent with the retention time and mass spectrometry of a DAPG reference standard. Based on the results, it was assumed the DAPG cluster was active but not highly expressed under these culture conditions. We evaluated DAPG production under a variety of culture conditions (71 different carbon sources using Biolog plates) to determine if we could improve expression of DAPG activity. Under all the growth conditions tested, none of the conditions significantly improved the production of DAPG.

LC–MS data from Chromobacterium vaccinii CR1. (A) Extracted ion-chromatograms of violacein (black-m/z 344.1–344.2 Da); and depsipeptide FR900359 (brown-m/z 1002.5–1002.6 Da); (B) mass spectrum of violacein; (C) tandem mass spectrum of violacein; (D) mass spectrum of FR900359; (E) tandem mass spectrum of FR900359.

To confirm the activity of the Chromobacterium phlACB gene cluster in the metabolism of DAPG, the cluster was transformed into E. coli. It should be noted that expression of the phlACB genes from Pseudomonas fluorescens in E. coli resulted in the conversion of phloroglucinol into 2-acetylphloroglucinol (MAPG, 20%) and 3% DAPG in the culture medium2. Initial testing of E. coli expressing phlACB from Chromobacterium did not produce DAPG from phloroglucinol. Achkar et al. also found that incubation of the E. coli transformant with DAPG led to complete conversion of DAPG to MAPG (9%) and phloroglucinol (22%) in 48 h2. This motivated us to establish the activity of phlACB in the direction of DAPG to phloroglucinol. Therefore, cultures were grown in 100 μg/ml DAPG to determine the activity of the transformation of DAPG to MAPG and phloroglucinol. DAPG biotransformation samples, from triplicate transformations, were analyzed by LC–UV–MS/MS to confirm the identity of the products (Fig. 4). Samples over the course of time during incubation were monitored by UV at 270 nm (top panel of Fig. 4A–D), the maximum absorbance for DAPG. The UV signal and extracted ion chromatogram of DAPG remained constant for the control reaction where plasmid-only E. coli was the biocatalyst over 48 h (Fig. 4A,C). E. coli expressing phlACB showed a decrease in UV and EIC signal for DAPG over the course of 48 h, while having an increased signal for MAPG (14.30 min as determined by UV and accurate mass, < 1 ppm error, due to the lack of authentic standard) and phloroglucinol (at 48 h, 2.92 min based on accurate mass and comparison with authentic standard). At longer reaction times with E. coli expressing phlACB, DAPG and MAPG signals decreased and additional UV peaks appeared.

LC–UV–MS data of control and transformed E. coli incubated with 100 μg/ml DAPG. Culture media was diluted 1:1 with 18MΩ water prior to analysis. Black-UV at 270 nm (λmax for DAPG); brown-extracted ion chromatogram from 211.05 to 211.07 m/z; green-extracted ion chromatogram from 169.00 to 169.20 m/z; blue-extracted ion chromatogram from 127.03 to 127.05 m/z. DAPG at 24.3 min, MAPG at 14.3 min, phloroglucinol at 2.9 min. (A) 8 h control. (B) 8 h phlACB. (C) 48 h control. (D) 48 h phlACB. E. Structures, masses, and pathway of DAPG degradation.

DAPG has been an important molecule in the bioactivities of rhizosphere colonizing Pseudomonas species and the subject of extensive investigations for 40 years12. It is for this reason we found it interesting to discover strains of C. vaccinii isolated from aquatic environments have the DAPG cluster26. The type strain of C. vaccinii and other representative isolates of C. vaccinii were originally isolated from the rhizosphere and water environments associated with native and cultivated cranberries (Vaccinium macrocarpon Ait.)33. This coincidence suggests that DAPG could provide a similar ecological function in Chromobacterium as seen in Pseudomonas species. In Pseudomonas species, DAPG has long been known to suppress phytopathogens and other microbes in the rhizosphere41. In addition, it was shown that DAPG containing Pseudomonas strains were a key component of disease suppressive soils in controlling the wheat root disease “take-all decline”5. It is possible that DAPG in Chromobacterium may play a similar ecological role for plants in bogs or similar aquatic environments. It is also noteworthy that these genera are only distantly related, and the closest shared clade is at the phylum level (Proteobacteria) with Chromobacterium belonging to the class Betaproteobacteria and Pseudomonas belonging to the class Gammaproteobacteria.

The distribution of the DAPG biosynthetic cluster in the Chromobacterium genus is confined to a few different clades. It is interesting to find all members of C. vaccinii, C. sphagni and C. sinusclupearum have this cluster (Fig. 1). However, these species have limited genome representation with 5, 2, and 2 whole genomes sequenced, respectively. This suggests there is a selection pressure to maintain the cluster in the species, notably in C. vaccinii where all strains are from diverse environments. The analysis also shows the DAPG cluster has broad geographical distribution with genomes from North America, South America, and Asia. In addition to the DAPG cluster, we identified two other biosynthetic clusters in the genomes of interest, depsipeptide FR900359 and violacein. Most strikingly, depsipeptide FR900359 occurred in tandem with DAPG in the C. vaccinii strains while violacein appeared in all Chromobacterium genomes with the exception of the two C. phragmitis genomes. It is not clear if DAPG and depsipeptide FR900359 are an adaptation to a specific ecological need or if their correlation is a coincidence.

The depsipeptide FR900359 was found to be a powerful and selective inhibitor of G protein-coupled receptors (GPCR) in humans and other mammals42,43. GPCRs are important elements for intracellular signal transduction which respond to external ligand binding and initial response cascades through guanosine triphosphate and guanosine diphosphate exchange44. Now depsipeptide FR900359 and closely related compounds, collectively known as chromodepsins, are important pharmacological tools for use as therapeutics and tools to study GPCR function45. Interestingly, chromodespins were initially isolated from a plant (Ardisia crenata) used in traditional medicine46. Later, it was discovered the compound was actually produced by an endosymbiotic bacteria belonging to the genus Burkholderia47. The ecological role of this compound is not well understood. Chromodespins demonstrate a lack of inhibition toward plant GPCRs43. It has been suggested that they may provide a benefit to their plant host by acting as a herbivore deterrent47. Interestingly, chromodespins have been shown to have insecticidal activity against bean bug (Riptortus pedestris), as well as inhibit the GPCRs of the pest insects white fly (Bemisia tabaci) and silk moth (Bombyx mori)45. This suggests strains of C. vacinnii may also be useful in the control of insect pests.

All Chromobacterium genomes except the two C. phragmitis genomes contained the purple pigmented compound violacein. Violacein has been reported to have a variety of bioactive properties. It has been shown to have antifungal properties against a large variety of phytopathogenic and human fungal pathogens48. It has been reported to have antibacterial activities49 and antinematicidal activities50. The compound showed antifeedant, larvicidal and pupicidal activities against Asian armyworm (Spodoptera litura Fab.)51. These broad-based bioactivities suggest that violacein may also contribute to the biocontrol potential of these Chromobacterium strains.

The phylogeny of the PhlD protein (Fig. 2) suggests all DAPG clusters in Chromobacterium share a common ancestor and the closest non-Chromobacterium ancestor likely originated in the Pseudomonas flourescens group. From the phylogenetic tree it is difficult to definitively infer if the cluster had one transfer event into Chromobacterium and some descendent lineages lost the biosynthetic cluster or if other horizontal gene transfer (HGT) events occurred within the Chromobacterium genus (e.g. a HGT from C. vaccinii to C. sinusclupearum).

In wild type C. vaccinii isolates, the production of DAPG could only be detected in trace amounts. Efforts to increase the production of DAPG through screening a variety of media conditions and carbon sources were unsuccessful. It may be possible that molecules in aquatic environments induce the biosynthesis of DAPG in Chromobacterium. Nevertheless, we confirmed that the biosynthetic genes in Chromobacterium for DAPG production were intact and functional. Our results also suggest the regulatory mechanism of Chromobacterium strains is significantly different than Pseudomonas strains since they lack the known regulatory genes phlG and phlH12. In addition, they lack the Pseudomonas post translational regulatory genes rsmA and rsmE (data not shown)12. More experiments will need to be performed in the future to discover the regulatory mechanism of DAPG production in Chromobacterium. We assumed the lack of activity was due to the lack of expression of these genes. We transferred the phlACB cluster into E. coli to have direct control over the expression of these genes. Initial testing of the transformant failed to produce DAPG from phloroglucinol. This is consistent with previous observations that expression of the phlACB cluster in E. coli produced no or trace amounts of DAPG2,52. However, in past studies the reverse reaction, conversion of DAPG to MAPG and phloroglucinol was active2,52. Monitoring of the reverse reaction showed a time-dependent decrease in the amount of DAPG present in the media when phlACB was expressed. There was an increase in the UV270nm at retention times corresponding to the exact mass of MAPG and phloroglucinol (Fig. 4E) demonstrating the cluster could convert DAPG to MAPG and phloroglucinol. It should be noted in experiments where E. coli expressing phlACB transformants were incubated with phloroglucinol in an attempt to produce DAPG, the phloroglucinol used contained a small DAPG (< 1%) impurity. When incubated with the E. coli expressing phlACB transformants, this DAPG impurity was converted to phloroglucinol and no reaction was observed in the direction of DAPG formation. It is unknown why phlACB transformants favored the production of phloroglucinol and the biotransformation to DAPG did not occur. However, Liu et al.52 recently demonstrated enhanced production of DAPG in E. coli expressing phlACB transformants through co-expression of acc, marA and phlE genes.

A survey of literature identified a few examples of strains of Chromobacterium being evaluated as potential biocontrol agents to control plant pathogens22,23,24,25. Two of the studies use Chromobacterium haemolyticum C-61, which displayed strong antifungal activities against several plant pathogens23,24. These studies identified another novel cyclic lipopeptide which they named chromobactomycin, which was responsible for the observed activity24. The genome is available for this strain, and it does not contain the DAPG cluster. Han et al. identified Chromobacterium sp. JH7 during a screening assay to identify antagonists of Cylindrocarpon destructans, a root rot pathogen of ginseng22,23,24,25. The authors were not able to identify the strain to the species level. It is possible that DAPG or depsipeptide FR900359 may be associated with this activity, but there is currently no data to support this speculation. In a recent study, C. vaccinii was shown to inhibit several fungal plant pathogens through emission of bioactive volatiles22,23,24,25. We could not find any reported DAPG activity in Chromobacterium sp. in the literature.

Our results confirm the presence and activity of the DAPG biosynthetic cluster in the Chromobacterium genus. These findings and the limited investigations of the biocontrol activity against plant pathogens by the Chromobacterium genus suggests additional research in this area is warranted.

All data generated or analyzed during this study are included in this published article. All sequence data generated by our laboratory are available at https://www.ncbi.nlm.nih.gov/bioproject/PRJNA782632.

Shanahan, P., O’Sullivan, D. J., Simpson, P., Glennon, J. D. & O’Gara, F. Isolation of 2,4-diacetylphloroglucinol from a fluorescent Pseudomonad and investigation of physiological parameters influencing its production. Appl. Environ. Microbiol. 58, 353–358. https://doi.org/10.1128/aem.58.1.353-358.1992 (1992).

Article ADS CAS PubMed PubMed Central Google Scholar

Achkar, J., Xian, M., Zhao, H. & Frost, J. W. Biosynthesis of phloroglucinol. J. Am. Chem. Soc. 127, 5332–5333. https://doi.org/10.1021/ja042340g (2005).

Article CAS PubMed Google Scholar

Bangera, M. G. & Thomashow, L. S. Identification and characterization of a gene cluster for synthesis of the polyketide antibiotic 2,4-diacetylphloroglucinol from pseudomonas fluorescens q2–87. J. Bacteriol. 181, 3155–3163. https://doi.org/10.1128/jb.181.10.3155-3163.1999 (1999).

Article CAS PubMed PubMed Central Google Scholar

Shanahan, P., Glennon, J. D., Crowley, J. J., Donnelly, D. F. & O’Gara, F. Liquid chromatographic assay of microbially derived phloroglucinol antibiotics for establishing the biosynthetic route to production, and the factors affecting their regulation. Anal. Chim. Acta 272, 271–277. https://doi.org/10.1016/0003-2670(93)80579-A (1993).

Article CAS Google Scholar

Raaijmakers, J. M. & Weller, D. M. Natural plant protection by 2,4-diacetylphloroglucinol-producing Pseudomonas spp. Take-all decline soils. Mol. Plant-Microbe Interact. 11, 144–152. https://doi.org/10.1094/MPMI.1998.11.2.144 (1998).

Article CAS Google Scholar

Haas, D. & Keel, C. in Annual Review of Phytopathology Vol. 41 117–153 (2003).

Cook, J. R. Take-all of wheat. Physiol. Mol. Plant Pathol. 62, 73–86. https://doi.org/10.1016/S0885-5765(03)00042-0 (2003).

Article Google Scholar

Almario, J., Muller, D., Défago, G. & Moënne-Loccoz, Y. Rhizosphere ecology and phytoprotection in soils naturally suppressive to Thielaviopsis black root rot of tobacco. Environ. Microbiol. 16, 1949–1960. https://doi.org/10.1111/1462-2920.12459 (2014).

Article PubMed Google Scholar

Fenton, A. M., Stephens, P. M., Crowley, J., O’Callaghan, M. & O’Gara, F. Exploitation of gene(s) involved in 2,4-diacetylphloroglucinol biosynthesis to confer a new biocontrol capability to a Pseudomonas strain. Appl. Environ. Microbiol. 58, 3873–3878. https://doi.org/10.1128/aem.58.12.3873-3878.1992 (1992).

Article ADS CAS PubMed PubMed Central Google Scholar

Cronin, D. et al. Ecological interaction of a biocontrol Pseudomonas fluorescens strain producing 2,4-diacetylphloroglucinol with the soft rot potato pathogen Erwinia carotovora subsp. atroseptica. FEMS Microbiol. Ecol. 23, 95–106. https://doi.org/10.1111/j.1574-6941.1997.tb00394.x (1997).

Lanteigne, C., Gadkar, V. J., Wallon, T., Novinscak, A. & Filion, M. Production of DAPG and HCN by Pseudomonas sp. LBUM300 contributes to the biological control of bacterial canker of Tomato. Phytopathology® 102, 967–973. https://doi.org/10.1094/phyto-11-11-0312 (2012).

Biessy, A. & Filion, M. Phloroglucinol derivatives in plant-beneficial Pseudomonas spp.: Biosynthesis, regulation, and functions. Metabolites 11. https://doi.org/10.3390/metabo11030182 (2021).

Mishra, J. & Arora, N. K. Secondary metabolites of fluorescent Pseudomonads in biocontrol of phytopathogens for sustainable agriculture. Appl. Soil. Ecol. 125, 35–45. https://doi.org/10.1016/j.apsoil.2017.12.004 (2018).

Article Google Scholar

Yang, F. & Cao, Y. Biosynthesis of phloroglucinol compounds in microorganisms—review. Appl. Microbiol. Biotechnol. 93, 487–495. https://doi.org/10.1007/s00253-011-3712-6 (2012).

Article CAS PubMed Google Scholar

Yang, C. H. & Li, Y. H. Chromobacterium violaceum infection: A clinical review of an important but neglected infection. J. Chin. Med. Assoc. 74, 435–441. https://doi.org/10.1016/j.jcma.2011.08.013 (2011).

Article PubMed Google Scholar

McClean, K. H. et al. Quorum sensing and Chromobacterium violaceum: Exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143, 3703–3711. https://doi.org/10.1099/00221287-143-12-3703 (1997).

Article CAS PubMed Google Scholar

Ueda, H. et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J. Antibiot. 47, 301–310. https://doi.org/10.7164/antibiotics.47.301 (1994).

Choi, S. Y., Yoon, K. H., Lee, J. I. & Mitchell, R. J. Violacein: Properties and production of a versatile bacterial pigment. BioMed Res. Int. 2015. https://doi.org/10.1155/2015/465056 (2015).

Taniguchi, M. et al. YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. J. Antibiot. 56, 358–363. https://doi.org/10.7164/antibiotics.56.358 (2003).

Ramirez, J. L. et al. Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities. PLoS Pathogens 10. https://doi.org/10.1371/journal.ppat.1004398 (2014).

Martin, P. A. W., Gundersen-Rindal, D., Blackburn, M. & Buyer, J. Chromobacterium subtsugae sp. nov., a betaproteobacterium toxic to Colorado potato beetle and other insect pests. Int. J. Syst. Evol. Microbiol. 57, 993–999. https://doi.org/10.1099/ijs.0.64611-0 (2007).

Han, J. H., Park, G. C. & Kim, K. S. Antagonistic evaluation of Chromobacterium sp. JH7 for biological control of ginseng root rot caused by Cylindrocarpon destructans. Mycobiology 45, 370–378. https://doi.org/10.5941/MYCO.2017.45.4.370 (2017).

Kim, H. J. et al. Both extracellular chitinase and a new cyclic lipopeptide, chromobactomycin, contribute to the biocontrol activity of Chromobacterium sp. C61. Mol. Plant Pathol. 15, 122–132. https://doi.org/10.1111/mpp.12070 (2014).

Kim, Y. C., Jung, H., Kim, K. Y. & Park, S. K. An effective biocontrol bioformulation against Phytophthora blight of pepper using growth mixtures of combined chitinolytic bacteria under different field conditions. Eur. J. Plant Pathol. 120, 373–382. https://doi.org/10.1007/s10658-007-9227-4 (2008).

Article Google Scholar

Ebadzadsahrai, G., Higgins Keppler, E. A., Soby, S. D. & Bean, H. D. Inhibition of fungal growth and induction of a novel volatilome in response to Chromobacterium vaccinii volatile organic compounds. Front. Microbiol. 11. https://doi.org/10.3389/fmicb.2020.01035 (2020).

Gomes, R. P. et al. Draft genome sequences of Chromobacterium strains isolated from water systems in Central Western Brazil. Microbiol. Resour. Announc. 11, e0041722 (2022).

Article PubMed Google Scholar

de São, C. A. D. E. https://cetesb.sp.gov.br/wp-content/uploads/2021/10/Guia-nacional-de-coleta-e-preservacao-de-amostras-2012.pdf (2011).

Gomes, R. P. et al. Occurrence of antibiotic resistance genes, antibiotics-resistant and multi-resistant bacteria and their correlations in one river in Central-Western Brazil. Water (Switzerland) 15, 1. https://doi.org/10.3390/w15040747 (2023).

Blin, K. et al. antiSMASH 6.0: Improving cluster detection and comparison capabilities. Nucleic Acids Res. 49, W29–W35. https://doi.org/10.1093/nar/gkab335 (2021).

Article CAS PubMed PubMed Central Google Scholar

Jolley, K. A. & Maiden, M. C. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinf. 11, 1–11 (2010).

Article Google Scholar

Tamura, K., Stecher, G. & Kumar, S. MEGA11: Molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022–3027. https://doi.org/10.1093/molbev/msab120 (2021).

Article CAS PubMed PubMed Central Google Scholar

Johnson, E. T., Dowd, P. F. & Hughes, S. R. Expression of a wolf spider toxin in tobacco inhibits the growth of microbes and insects. Biotechnol. Lett. 36, 1735–1742. https://doi.org/10.1007/s10529-014-1536-z (2014).

Article CAS PubMed Google Scholar

Soby, S. D., Gadagkar, S. R., Contreras, C. & Caruso, F. L. Chromobacterium vaccinii sp. nov., isolated from native and cultivated cranberry (Vaccinium macrocarpon Ait.) bogs and irrigation ponds. Int. J. Syst. Evol. Microbiol. 63, 1840–1846 (2013).

Crüsemann, M. et al. Heterologous expression, biosynthetic studies, and ecological function of the selective Gq-signaling inhibitor FR900359. Angew. Chem. Int. Ed. 57, 836–840. https://doi.org/10.1002/anie.201707996 (2018).

Article CAS Google Scholar

Hara-Hanley, K., Harrison, A. & Soby, S. D. Chromobacterium alticapitis sp. nov. and Chromobacterium sinusclupearum sp. nov. isolated from wild cranberry bogs in the Cape Cod National Seashore, USA. Int. J. Syst. Evol. Microbiol. 72. https://doi.org/10.1099/ijsem.0.005410 (2022).

Blackburn, M. B. et al. Chromobacterium sphagni sp. Nov., an insecticidal bacterium isolated from sphagnum bogs. Int. J. Syst. Evol. Microbiol. 67, 3417–3422. https://doi.org/10.1099/ijsem.0.002127 (2017).

O’Hara-Hanley, K., Harrison, A. & Soby, S. D. Draft genomic sequences of Chromobacterium sp. nov. strains MWU13-2610 and MWU14-2602, isolated from wild cranberry bogs in Massachusetts. Genome Announc. 6, e00332–00318. https://doi.org/10.1128/genomeA.00332-18 (2018).

Vöing, K., Harrison, A. & Soby, S. D. Draft genome sequence of Chromobacterium vaccinii, a potential biocontrol agent against mosquito (Aedes aegypti) larvae. Genome Announc. 3. https://doi.org/10.1128/genomeA.00477-15 (2015).

Chan, K. G. & Yunos, N. Y. M. Whole-genome sequencing analysis of chromobacterium piscinae strain ND17, a quorum-sensing bacterium. Genome Announc. 4. https://doi.org/10.1128/genomeA.00081-16 (2016).

Gomila, M., Peña, A., Mulet, M., Lalucat, J. & García-Valdés, E. Phylogenomics and systematics in Pseudomonas. Front Microbiol 6, 214 (2015).

Article PubMed PubMed Central Google Scholar

Keel, C. et al. Suppression of root diseases by Pseudomonas fluorescens CHA0: Importance of the bacterial secondary metabolite 2,4-diacetylphloroglucinol. Mol. Plant-Microbe Interact. 5, 4–13 (1992).

Article CAS Google Scholar

Nishimura, A. et al. Structural basis for the specific inhibition of heterotrimeric G q protein by a small molecule. Proc. Natl. Acad. Sci. U.S.A. 107, 13666–13671. https://doi.org/10.1073/pnas.1003553107 (2010).

Article ADS PubMed PubMed Central Google Scholar

Schrage, R. et al. The experimental power of FR900359 to study Gq-regulated biological processes. Nat. Commun. 6. https://doi.org/10.1038/ncomms10156 (2015).

Hilger, D., Masureel, M. & Kobilka, B. K. Structure and dynamics of GPCR signaling complexes. Nat. Struct. Mol. Biol. 25, 4–12. https://doi.org/10.1038/s41594-017-0011-7 (2018).

Article CAS PubMed PubMed Central Google Scholar

Hermes, C., König, G. M. & Crüsemann, M. The chromodepsins-chemistry, biology and biosynthesis of a selective Gq inhibitor natural product family. Nat. Prod. Rep. 38, 2276–2292. https://doi.org/10.1039/d1np00005e (2021).

Article CAS PubMed Google Scholar

Fujioka, M., Koda, S., Morimoto, Y. & Biemann, K. Structure of FR900359, a cyclic depsipeptide from Ardisia Crenata Sims. J. Org. Chem. 53, 2820–2825. https://doi.org/10.1021/jo00247a030 (1988).

Article CAS Google Scholar

Carlier, A. et al. The genome analysis of Candidatus Burkholderia crenata reveals that secondary metabolism may be a key function of the Ardisia crenata leaf nodule symbiosis. Environ. Microbiol. 18, 2507–2522. https://doi.org/10.1111/1462-2920.13184 (2016).

Article CAS PubMed Google Scholar

Durán, N. et al. Violacein and its antifungal activity: Comments and potentialities. Lett. Appl. Microbiol. 75, 796–803. https://doi.org/10.1111/lam.13760 (2022).

Article CAS PubMed Google Scholar

Durán, N. et al. Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review. Biotechnol. Adv. 34, 1030–1045. https://doi.org/10.1016/j.biotechadv.2016.06.003 (2016).

Article CAS PubMed Google Scholar

Ballestriero, F. et al. Antinematode activity of violacein and the role of the insulin/IGF-1 pathway in controlling violacein sensitivity in Caenorhabditis elegans. PLoS One 9. https://doi.org/10.1371/journal.pone.0109201 (2014).

Baskar, K. & Ignacimuthu, S. Bioefficacy of violacein against Asian armyworm Spodoptera litura Fab. (Lepidoptera: Noctuidae). J. Saudi Soc. Agric. Sci. 11, 73–77, doi:https://doi.org/10.1016/j.jssas.2011.10.002 (2012).

Liu, W., Zhang, R. & Xian, M. Biosynthesis of 2,4-diacetylphloroglucinol from glucose using engineered Escherichia coli. World J. Microbiol. Biotechnol. 36, 130. https://doi.org/10.1007/s11274-020-02906-2 (2020).

Article CAS PubMed Google Scholar

Download references

The authors would like to thank Madeleine Adolf, Mark Doering, and Heather Walker for expert technical assistance. This work was supported in part by the U.S. Department of Agriculture, Agricultural Research Service (Project Number: 5010-22410-024-00-D). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The mention of firm names or trade products does not imply they are endorsed or recommended by the USDA over other firms or similar products not mentioned. USDA is an equal opportunity provider and employer.

United States Department of Agriculture, Agricultural Research Service, National Center for Agricultural Utilization Research, Crop Bioprotection Research Unit, 1815 North University St, Peoria, IL, 61604, USA

Eric T. Johnson & Christopher A. Dunlap

United States Department of Agriculture, Agricultural Research Service, National Center for Agricultural Utilization Research, Bioenergy Research Unit, 1815 North University St, Peoria, IL, 61604, USA

Michael J. Bowman

Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil

Raylane Pereira Gomes & Lilian Carla Carneiro

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

All authors listed have made substantial or indirect contributions to the work and in the design of experiments. R.P.G. collected the samples and data. M.B., C.D. conducted the metabolomics and analyzed the data and E.J. conducted the molecular biology experiments, C.D. conducted the comparative genomic, phylogeny and wrote the manuscript. C.D., M.B., E.J., R.P.G. and L.C.C. read the paper and revised the manuscript. All authors approved the final manuscript.

Correspondence to Christopher A. Dunlap.

The authors declare no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

Johnson, E.T., Bowman, M.J., Gomes, R.P. et al. Identification of 2,4-diacetylphloroglucinol production in the genus Chromobacterium. Sci Rep 13, 14292 (2023). https://doi.org/10.1038/s41598-023-41277-0

Download citation

Received: 01 March 2023

Accepted: 24 August 2023

Published: 31 August 2023

DOI: https://doi.org/10.1038/s41598-023-41277-0

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.